These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 21858240)

  • 21. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.
    Warfield KL; Olinger G; Deal EM; Swenson DL; Bailey M; Negley DL; Hart MK; Bavari S
    J Immunol; 2005 Jul; 175(2):1184-91. PubMed ID: 16002721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
    Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
    PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus.
    Anguiano-Zarate SS; Matchett WE; Nehete PN; Sastry JK; Marzi A; Barry MA
    J Infect Dis; 2018 Nov; 218(12):1883-1889. PubMed ID: 29982595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine.
    Farooq F; Beck K; Paolino KM; Phillips R; Waters NC; Regules JA; Bergmann-Leitner ES
    Sci Rep; 2016 Jun; 6():27944. PubMed ID: 27323685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
    Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
    Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge.
    Lehrer AT; Wong TS; Lieberman MM; Johns L; Medina L; Feldmann F; Feldmann H; Marzi A
    Vaccine; 2019 Nov; 37(47):6942-6950. PubMed ID: 31324500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.
    Heppner DG; Kemp TL; Martin BK; Ramsey WJ; Nichols R; Dasen EJ; Link CJ; Das R; Xu ZJ; Sheldon EA; Nowak TA; Monath TP;
    Lancet Infect Dis; 2017 Aug; 17(8):854-866. PubMed ID: 28606591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs.
    Richardson JS; Abou MC; Tran KN; Kumar A; Sahai BM; Kobinger GP
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1032-42. PubMed ID: 21987739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
    Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
    mBio; 2019 May; 10(3):. PubMed ID: 31138743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.
    Falzarano D; Feldmann F; Grolla A; Leung A; Ebihara H; Strong JE; Marzi A; Takada A; Jones S; Gren J; Geisbert J; Jones SM; Geisbert TW; Feldmann H
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1082-9. PubMed ID: 21987745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine.
    Medaglini D; Siegrist CA
    Curr Opin Virol; 2017 Apr; 23():88-94. PubMed ID: 28460340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein.
    Wilson JA; Hart MK
    J Virol; 2001 Mar; 75(6):2660-4. PubMed ID: 11222689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.
    Marzi A; Robertson SJ; Haddock E; Feldmann F; Hanley PW; Scott DP; Strong JE; Kobinger G; Best SM; Feldmann H
    Science; 2015 Aug; 349(6249):739-42. PubMed ID: 26249231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
    Ewer K; Rampling T; Venkatraman N; Bowyer G; Wright D; Lambe T; Imoukhuede EB; Payne R; Fehling SK; Strecker T; Biedenkopf N; Krähling V; Tully CM; Edwards NJ; Bentley EM; Samuel D; Labbé G; Jin J; Gibani M; Minhinnick A; Wilkie M; Poulton I; Lella N; Roberts R; Hartnell F; Bliss C; Sierra-Davidson K; Powlson J; Berrie E; Tedder R; Roman F; De Ryck I; Nicosia A; Sullivan NJ; Stanley DA; Mbaya OT; Ledgerwood JE; Schwartz RM; Siani L; Colloca S; Folgori A; Di Marco S; Cortese R; Wright E; Becker S; Graham BS; Koup RA; Levine MM; Volkmann A; Chaplin P; Pollard AJ; Draper SJ; Ballou WR; Lawrie A; Gilbert SC; Hill AV
    N Engl J Med; 2016 Apr; 374(17):1635-46. PubMed ID: 25629663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and epitope mapping of a monoclonal antibody against nucleoprotein of Ebola virus.
    Wang X; Liu Y; Wang H; Shi Z; Zhao F; Wei J; Shao D; Ma Z
    Sheng Wu Gong Cheng Xue Bao; 2012 Nov; 28(11):1317-27. PubMed ID: 23457784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees?
    Walsh PD; Kurup D; Hasselschwert DL; Wirblich C; Goetzmann JE; Schnell MJ
    Sci Rep; 2017 Mar; 7():43339. PubMed ID: 28277549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and evaluation of DNA vaccine encoding Ebola virus glycoprotein fused with lysosome-associated membrane protein.
    Liu Y; Sun B; Pan J; Feng Y; Ye W; Xu J; Lan M; Sun H; Zhang X; Sun Y; Yang S; Shi J; Zhang F; Cheng L; Jiang D; Yang K
    Antiviral Res; 2021 Sep; 193():105141. PubMed ID: 34274417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals.
    Wong G; Richardson JS; Cutts T; Qiu X; Kobinger GP
    Antiviral Res; 2015 Apr; 116():17-9. PubMed ID: 25596432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes.
    Sundar K; Boesen A; Coico R
    Virology; 2007 Apr; 360(2):257-63. PubMed ID: 17123567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.